<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04965610</url>
  </required_header>
  <id_info>
    <org_study_id>070720211</org_study_id>
    <nct_id>NCT04965610</nct_id>
  </id_info>
  <brief_title>Preoxygenation With High Flow Nasal Cannula Prolongs Normoxia Time During Induction of Anaesthesia of Bariatric Patients and is Superior to Conventional Preoxygenation With Face Mask.</brief_title>
  <official_title>Preoxygenation With High Flow Nasal Cannula Prolongs Normoxia Time During Induction of Anaesthesia of Bariatric Patients and is Superior to Conventional Preoxygenation With Face Mask.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Staedtisches Klinikum Karlsruhe</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Staedtisches Klinikum Karlsruhe</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare preoxygenation for induction of general anaesthesia with High Flow Nasal Cannula&#xD;
      vs preoxygenation with face mask in patients undergoing bariatric surgery. The hypothesis is&#xD;
      that preoxygenation with High Flow Nasal Cannula prolongs normoxia time during induction of&#xD;
      anaeshesia and is superior to conventional preoxygenation with face mask. Primary endpoint&#xD;
      will be the time during which spO2 &gt; 92 %. Secondary endpoint will be paCO2.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two groups of patients. One receiving preoxygenation via High Flow Nasal Cannula and one group receiving preoxygenation via face mask</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Patients will be divided into two groups by lot.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Normoxia time SpO2 &gt; 92%</measure>
    <time_frame>10 Minutes after induction</time_frame>
    <description>Time in which the SpO2 remains &gt; 92% while patient is apnoeic</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>paCO2</measure>
    <time_frame>10 Minutes after induction</time_frame>
    <description>Increase in arterial CO2 during Apnoea</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Compare Preoxygenation Methods in Bariatric Patients</condition>
  <arm_group>
    <arm_group_label>Preoxygenation via THRIVE/High Flow Nasal Cannula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive preoxygenation for induction of general anaesthesia via High Flow Nasal Cannula for the duration of 5 minutes. After that the induction agents will be given. Now arterial blood gases will be drawn every 2 minutes and the SpO2 will be measured until the 6th apnoeic ABG or if the SpO2 decreases to 92%. After that normal intubation follows.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preoxygenation via face mask (PROX)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive preoxygenation for induction of general anaesthesia via tight fitting face mask for the duration of 5 minutes. After that the induction agents will be given. Now arterial blood gases will be drawn every 2 minutes and the SpO2 will be measured until the 6th apnoeic ABG or if the SpO2 decreases to 92%. After that normal intubation follows.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Preoxygenation with High Flow Nasal Cannula</intervention_name>
    <description>Preoxygenation for 5 minutes via High Flow Nasal Cannula. After induction of anaesthesia apnoeic oxygenation with HFNC</description>
    <arm_group_label>Preoxygenation via THRIVE/High Flow Nasal Cannula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Preoxygenation via face mask</intervention_name>
    <description>Preoxygenation for 5 minutes via face mask. After induction of anaesthesia apnoeic oxygenation with tight fitting face mask</description>
    <arm_group_label>Preoxygenation via face mask (PROX)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age over 18&#xD;
&#xD;
          -  elective bariatric surgery&#xD;
&#xD;
          -  written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  preexisting lung diseases, congenital heart diseases&#xD;
&#xD;
          -  known difficult airway&#xD;
&#xD;
          -  SpO2 &lt; 92% under ambient air conditions&#xD;
&#xD;
          -  known diaphragmal hernia&#xD;
&#xD;
          -  clinically relevant reflux&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joachim Jugl</last_name>
    <role>Principal Investigator</role>
    <affiliation>Senior Resident Anaesthesia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Franz Kehl, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Head of Department of Anaesthesia and Intensive Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joachim Jugl</last_name>
    <phone>004972197467846</phone>
    <email>Joachim.Jugl@klinikum-karlsruhe.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Franz Kehl, Prof.</last_name>
    <phone>00497219741601</phone>
  </overall_contact_backup>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 7, 2021</study_first_submitted>
  <study_first_submitted_qc>July 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2021</study_first_posted>
  <last_update_submitted>July 7, 2021</last_update_submitted>
  <last_update_submitted_qc>July 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Staedtisches Klinikum Karlsruhe</investigator_affiliation>
    <investigator_full_name>Joachim Jugl</investigator_full_name>
    <investigator_title>Assistenzarzt An√§sthesie</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

